详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Yu, Jiayi[1,2,3,4,5,6,7,8,9,10,11,12,13] * ; Jiang, Leilei[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhao, Lina[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Wang, Xiaomin[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Yang, Xue[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Yang, Dan[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhuo, Minglei[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Chen, Hanxiao[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhao, Yidian[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhou, Fang[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Li, Quanfu[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhu, Zhengfei[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Chu, Li[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Ma, Zhanshu[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Wang, Qifeng[1,2,3,4,5,6,7,8,9,10,11,12,13]

; Qu, Yanli[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Yu, Huiming[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Yu, Rong[1,2,3,4,5,6,7,8,9,10,11,12,13] ; Zhao, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13]

; Shi, Anhui[1,2,3,4,5,6,7,8,9,10,11,12,13] ;

机构： [1]Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Radiat Oncol, Minist Educ, Beijing, Peoples R China [2]Air Force Mil Med Univ, Affiliated Hosp 1, Xijing Hosp, Xian, Peoples R China [3]Anyang Canc Hosp, Anyang, Peoples R China [4]Beijing Univ Canc Hosp & Inst, Beijing, Peoples R China [5]Peking Univ Canc Hosp & Inst, Dept Thorac Med Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China [6]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China [7]Yantai Yuhuangding Hosp, Yantai, Peoples R China [8]Ordos Sch Clin Med IMMU, Ordos, Peoples R China [9]Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China [10]Chifeng Affiliated Hosp, Chifeng, Peoples R China [11]Univ Elect Sci & Technol China, Sch Med,Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Chengdu 610042, Peoples R China [12]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China [13]Peking Univ Canc Hosp & Inst, Dept Radiat Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Radiat Oncol, Minist Educ, Beijing, Peoples R China [2]Air Force Mil Med Univ, Affiliated Hosp 1, Xijing Hosp, Xian, Peoples R China [3]Anyang Canc Hosp, Anyang, Peoples R China [4]Beijing Univ Canc Hosp & Inst, Beijing, Peoples R China [5]Peking Univ Canc Hosp & Inst, Dept Thorac Med Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China [6]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China [7]Yantai Yuhuangding Hosp, Yantai, Peoples R China [8]Ordos Sch Clin Med IMMU, Ordos, Peoples R China [9]Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China [10]Chifeng Affiliated Hosp, Chifeng, Peoples R China [11]Univ Elect Sci & Technol China, Sch Med,Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Chengdu 610042, Peoples R China [12]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China [13]Peking Univ Canc Hosp & Inst, Dept Radiat Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and safety of high dose twice-daily thoracic radiotherapy versus standard dose for limited stage small-cell lung cancer: A multicentre, open-label randomised, phase 3 trial

文献详情